ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 2 filers reported holding ARRAY BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,633,000 | +90.0% | 100,000 | 0.0% | 0.54% | +87.7% |
| Q1 2019 | $2,438,000 | +71.1% | 100,000 | 0.0% | 0.28% | +53.2% |
| Q4 2018 | $1,425,000 | -6.2% | 100,000 | 0.0% | 0.19% | +9.4% |
| Q3 2018 | $1,520,000 | -9.4% | 100,000 | 0.0% | 0.17% | -12.8% |
| Q2 2018 | $1,678,000 | +46.9% | 100,000 | +42.9% | 0.20% | +43.4% |
| Q1 2018 | $1,142,000 | +41.7% | 70,000 | +11.1% | 0.14% | +38.8% |
| Q4 2017 | $806,000 | +31.1% | 63,000 | +26.0% | 0.10% | +25.6% |
| Q3 2017 | $615,000 | +47.1% | 50,000 | 0.0% | 0.08% | +39.3% |
| Q2 2017 | $418,000 | -6.5% | 50,000 | 0.0% | 0.06% | -9.7% |
| Q1 2017 | $447,000 | +408.0% | 50,000 | +400.0% | 0.06% | +376.9% |
| Q4 2016 | $88,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |